22.76 USD
▲+0.83+3.29%
盘后 21.87 -0.73%
2026-08-03
市值
$235.65M
市盈率
—
EPS
-3.93
股息率
—
52 周区间
5.26 – 24.92
成交量
57.28K
Beta
0.52
目标价
30.83
52W 低 5.2652W 高 24.92
价格走势
公司简介
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to...